Literature DB >> 19577064

Risk factors for early pulmonary valve replacement after valve disruption in congenital pulmonary stenosis and tetralogy of Fallot.

Brian Kogon1, Courtney Plattner, Paul Kirshbom, Kirk Kanter, Traci Leong, Theresa Lyle, Staci Jennings, Mike McConnell, Wendy Book.   

Abstract

OBJECTIVE: Congenital heart defects with a component of pulmonary stenosis are often palliated in childhood by disrupting the pulmonary valve, either by means of dilation or excision. It is unclear what factors affect a patient's ability to tolerate long-term pulmonary insufficiency before requiring pulmonary valve replacement. We analyze potential factors that are related to the interval between pulmonary valve disruption and pulmonary valve replacement.
METHODS: One hundred seven patients were analyzed. They had a congenital diagnosis of pulmonary stenosis or tetralogy of Fallot, had their first pulmonary valve replacement between 2002 and 2008, and had a known interval between pulmonary valve disruption and pulmonary valve replacement. The median age at the time of surgical intervention was 2 years for pulmonary valve disruption (range, 0-56 years) and 26 years for pulmonary valve replacement (range, 1-72 years). The median interval was 23 years (range, 0-51 years). Potential related factors were sex, race, initial diagnosis and procedure, age at pulmonary valve disruption, prior shunt operation, presence of branch pulmonary artery stenosis, and degree of pulmonary regurgitation.
RESULTS: As determined by using univariate analysis, male patients had a shorter interval than female patients (median, 16 vs 26 years; P = .01), and African American patients had a shorter interval than white patients (median, 16 vs 25 years; P = .049). A significant correlation was also identified between age at the time of pulmonary valve disruption and the subsequent interval to pulmonary valve replacement. Overall, the interval tended to increase as age at disruption increased (P < .0001). Although the presence of branch pulmonary artery stenosis determined by the need for concomitant pulmonary arterioplasty was associated with a significantly shorter interval to pulmonary valve replacement (21 vs 24 years, P = .02), stenosis determined based on small branch pulmonary artery diameter was correlated to a prolonged interval to pulmonary valve replacement (P = .009). Initial diagnosis, prior palliative shunt operation, and degree of pulmonary regurgitation had no effect on the interval between pulmonary valve disruption and subsequent pulmonary valve replacement. As determined by using multivariate analysis, only male sex and small pulmonary artery diameter remained significant factors.
CONCLUSIONS: Male sex appears to shorten the interval between pulmonary valve disruption and pulmonary valve replacement, whereas small branch pulmonary artery diameter appears to lengthen the interval. Knowing which factors are detrimental and which are protective might help identify patients who are prone to a more rapid progression of right heart failure from free pulmonary insufficiency, possibly steering them toward more frequent follow-up or more aggressive heart failure medical regimens.

Entities:  

Mesh:

Year:  2009        PMID: 19577064     DOI: 10.1016/j.jtcvs.2009.02.020

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  7 in total

1.  Comparison of long-term postoperative sequelae in patients with tetralogy of Fallot versus isolated pulmonic stenosis.

Authors:  Michael J Zdradzinski; Athar M Qureshi; Robert Stewart; Gosta Pettersson; Richard A Krasuski
Journal:  Am J Cardiol       Date:  2014-05-02       Impact factor: 2.778

2.  Pulmonary stenosis and pulmonary regurgitation: both ends of the spectrum in residual hemodynamic impairment after tetralogy of Fallot repair.

Authors:  Byung Won Yoo; Han Ki Park
Journal:  Korean J Pediatr       Date:  2013-06-21

Review 3.  Repaired tetralogy of Fallot: the roles of cardiovascular magnetic resonance in evaluating pathophysiology and for pulmonary valve replacement decision support.

Authors:  Tal Geva
Journal:  J Cardiovasc Magn Reson       Date:  2011-01-20       Impact factor: 5.364

Review 4.  Matters of the heart: Cellular sex differences.

Authors:  Cierra J Walker; Megan E Schroeder; Brian A Aguado; Kristi S Anseth; Leslie A Leinwand
Journal:  J Mol Cell Cardiol       Date:  2021-06-22       Impact factor: 5.763

5.  Effect of Pulmonary Valve Replacement in the Repaired Tetralogy of Fallot Patients with Trans-annular Incision: More than 20 Years of Follow-up.

Authors:  Jae Gun Kwak; Hong Ju Shin; Ji Hyun Bang; Eung Re Kim; Jeong Ryul Lee; Woong Han Kim; Eun Jung Bae; Mi Kyoung Song; Gi Beom Kim
Journal:  Korean Circ J       Date:  2021-04       Impact factor: 3.243

6.  Risk Factors of Right Ventricular Dysfunction and Adverse Cardiac Events in Patients with Repaired Tetralogy of Fallot.

Authors:  Benedetta Leonardi; Camilla Calvieri; Marco Alfonso Perrone; Arianna Di Rocco; Adriano Carotti; Massimo Caputo; Aurelio Secinaro; Davide Curione; Maria Giulia Gagliardi; Paolo Guccione; Sonia Albanese; Lorenzo Galletti; Fabrizio Drago
Journal:  Int J Environ Res Public Health       Date:  2021-10-08       Impact factor: 3.390

7.  Evaluation of right ventricular function in operated tetralogy of Fallot patients with tissue Doppler imaging before and after pulmonary valve replacement.

Authors:  Hazım Alper Gürsu; Birgül Varan; İlkay Erdoğan; Murat Özkan
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2018-07-03       Impact factor: 0.332

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.